PH30211A - Use of ifn-gamma for the treatment of infections in transplant recipients - Google Patents

Use of ifn-gamma for the treatment of infections in transplant recipients

Info

Publication number
PH30211A
PH30211A PH45050A PH45050A PH30211A PH 30211 A PH30211 A PH 30211A PH 45050 A PH45050 A PH 45050A PH 45050 A PH45050 A PH 45050A PH 30211 A PH30211 A PH 30211A
Authority
PH
Philippines
Prior art keywords
treatment
gamma
ifn
infections
transplant recipients
Prior art date
Application number
PH45050A
Other languages
English (en)
Inventor
Christine Czarniecki
Jon B Klein
David A Slater
Gerald Sonnenfeld
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PH30211A publication Critical patent/PH30211A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH45050A 1991-10-07 1992-10-06 Use of ifn-gamma for the treatment of infections in transplant recipients PH30211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/773,382 US5248499A (en) 1991-10-07 1991-10-07 Control of microbial infections in transplant patients

Publications (1)

Publication Number Publication Date
PH30211A true PH30211A (en) 1997-02-05

Family

ID=25098084

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45050A PH30211A (en) 1991-10-07 1992-10-06 Use of ifn-gamma for the treatment of infections in transplant recipients

Country Status (20)

Country Link
US (1) US5248499A (es)
EP (1) EP0607258B1 (es)
JP (1) JP3467037B2 (es)
KR (1) KR100262063B1 (es)
AT (1) ATE146967T1 (es)
AU (1) AU666138B2 (es)
CA (1) CA2119236C (es)
DE (1) DE69216419T2 (es)
DK (1) DK0607258T3 (es)
ES (1) ES2097929T3 (es)
FI (1) FI941552A7 (es)
GR (1) GR3022672T3 (es)
HU (1) HU226455B1 (es)
IL (1) IL103341A (es)
NO (1) NO313576B1 (es)
NZ (1) NZ244615A (es)
PH (1) PH30211A (es)
PT (1) PT100932B (es)
WO (1) WO1993006847A1 (es)
ZA (1) ZA927677B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724838D0 (en) * 1997-11-26 1998-01-21 Franks Christopher R Compositions
EP1221976A4 (en) * 1999-09-28 2003-12-03 Amarillo Biosciences Inc IFN-GAMA IN LOW DOSAGE FOR TREATING DISEASES
CN1527721A (zh) * 2000-09-12 2004-09-08 基因特罗生物治疗公司 含治疗性蛋白混合物的组合物及其生产方法
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
AU2002246955B2 (en) * 2001-01-09 2007-03-22 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
PT1435910E (pt) * 2001-10-19 2009-09-07 Isotechnika Inc Novos pré-concentrados de microemulsão de análogos da ciclosporina
CA2536041A1 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20070116678A1 (en) * 2005-11-23 2007-05-24 Hsing-Wen Sung Medical device with living cell sheet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2237767A (en) * 1989-11-09 1991-05-15 Cosgrove Tools Ltd Moulding machine ejector devices

Also Published As

Publication number Publication date
IL103341A (en) 1997-11-20
HU226455B1 (en) 2008-12-29
DK0607258T3 (da) 1997-04-14
NZ244615A (en) 1997-06-24
AU666138B2 (en) 1996-02-01
PT100932B (pt) 1999-07-30
AU2762292A (en) 1993-05-03
DE69216419D1 (de) 1997-02-13
JP3467037B2 (ja) 2003-11-17
HUT67008A (en) 1995-01-30
IL103341A0 (en) 1993-03-15
NO941242D0 (no) 1994-04-06
ATE146967T1 (de) 1997-01-15
GR3022672T3 (en) 1997-05-31
EP0607258B1 (en) 1997-01-02
ES2097929T3 (es) 1997-04-16
HU9400984D0 (en) 1994-07-28
PT100932A (pt) 1993-10-29
CA2119236A1 (en) 1993-04-15
FI941552L (fi) 1994-04-05
NO941242L (no) 1994-06-03
FI941552A0 (fi) 1994-04-05
KR100262063B1 (ko) 2000-07-15
US5248499A (en) 1993-09-28
KR940702735A (ko) 1994-09-17
WO1993006847A1 (en) 1993-04-15
CA2119236C (en) 2007-05-22
ZA927677B (en) 1994-04-07
EP0607258A1 (en) 1994-07-27
FI941552A7 (fi) 1994-04-05
DE69216419T2 (de) 1997-06-26
JPH07500106A (ja) 1995-01-05
NO313576B1 (no) 2002-10-28

Similar Documents

Publication Publication Date Title
GR3024022T3 (en) Pharmaceutical and dermocosmetic compositions containing equine colostrum.
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
GB2288732B (en) Pharmaceutical compositions
DE69200837D1 (en) 3-difluoromethylpyrazolcarboxamidfungizide.
IL138522A0 (en) Use of cabergoline in the treatment of restless legs syndrome
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
MY138285A (en) Fab i inhibitors
GR3022672T3 (en) Use of ifn-gamma for the treatment of infections in transplant recipients.
EP0610286A4 (en) Recombinant immunotoxins.
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
PL318298A1 (en) Thiopyridil compounds for fighting against heliobacter
AU656543B2 (en) A process for the preparation of a pasteurized and iron-free human transferrin and the use thereof
ZA98420B (en) Use of pramipexole in the treatment of restless legs syndrome.
DK0863981T3 (da) Detektering, forebyggelse og behandling af papillomatous digital dermatitis
EP0619744A4 (en) NON-IONIC RADIOGRAPHIC CONTRAST METHODS, COMPOSITIONS AND AGENTS.
GEP20074097B (en) Use of specific dose of fondaparinux sodium for the treatment of acs
AU8870791A (en) Use of temocillin or carbenicillin for the treatment or prophylaxis of bacterial infections in fish
MY110041A (en) Composition and method of treating hepatitis c
IT1244360B (it) Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale